Drug Shortage Report for HUMULIN R

Last updated on 2024-09-18 History
Report ID 236640
Drug Identification Number 00586714
Brand name HUMULIN R
Common or Proper name Insulin, human biosynthetic
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN SEMI SYNTHETIC HUMAN
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size Carton package containing one 10 mL vial
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-09-03
Estimated end date 2024-09-17
Actual end date 2024-09-17
Shortage status Resolved
Updated date 2024-09-18
Company comments The following presentations remain available: Humulin® R 3.0 mL, 100 units /mL, 5 cartridges/box HI0219 (DIN 01959220), Humulin® R 3.0 mL prefilled pen, 100 units/mL, KwikPen HP8804 (DIN 02415089) The estimated end date represents projected availability at the main Lilly warehouse. For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-09-18 English Compare
v5 2024-09-17 French Compare
v4 2024-09-17 English Compare
v3 2024-09-04 French Compare
v2 2024-09-04 English Compare
v1 2024-09-04 English Compare

Showing 1 to 6 of 6